Authors: Ten Hagen, TLM Seynhaeve, ALB Van Tiel, ST Ruiter, DJ Eggermont, AMM

Citation: Tlm. Ten Hagen et al., Pegylated liposomal tumor necrosis factor-alpha results in reduced toxicity and synergistic antitumor activity after systemic administration in combination with liposomal doxorubicin (Doxil (R)) in soft tissue sarcoma-bearing rats, INT J CANC, 97(1), 2002, pp. 115-120

Authors: Kim, DW Andres, ML Li, J Kajioka, EH Miller, GM Seynhaeve, ALB Ten Hagen, TLM Gridley, DS

Citation: Dw. Kim et al., Liposome-encapsulated tumor necrosis factor-alpha enhances the effects of radiation against human colon tumor xenografts, J INTERF CY, 21(11), 2001, pp. 885-897

Authors: Van der Veen, AH Ten Hagen, TLM De Wilt, JHW Van Ijken, MGA Eggermont, AMM

Citation: Ah. Van Der Veen et al., An overview on the use of TNF-alpha: Our exprerience with regional administration and developments towards new opportunities for systemic application, ANTICANC R, 20(5B), 2000, pp. 3467-3474

Authors: De Wilt, JHW Soma, GI Ten Hagen, TLM Kanou, J Takagi, K Nooijen, PTGA Seynhaevel, ALB Eggermont, AMM

Citation: Jhw. De Wilt et al., Synergistic antitumour effect of TNF-SAM2 with melphalan and doxorubicin in isolated limb perfusion in rats, ANTICANC R, 20(5B), 2000, pp. 3491-3496

Authors: Ten Hagen, TLM Van Der Veen, AH Nooijen, PTGA Van Tiel, ST Seynhaeve, ALB Eggermont, AMM

Citation: Tlm. Ten Hagen et al., Low-dose tumor necrosis factor-alpha augments antitumor activity of stealth liposomal doxorubicin (Doxil (R)) in soft tissue sarcoma-bearing rats, INT J CANC, 87(6), 2000, pp. 829-837

Authors: Manusama, ER De Wilt, JHW Ten Hagen, TLM Marquet, RL Eggermont, AMM

Citation: Er. Manusama et al., Toxicity and antitumor activity of interferon gamma alone and in combinations with TNF alpha and melphalan in isolated limb perfusion in the BN175 sarcoma tumor model in rats, ONCOL REP, 6(1), 1999, pp. 173-177